These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30145215)

  • 1. Dyspnea in Amyotrophic Lateral Sclerosis: Rasch-Based Development and Validation of a Patient-Reported Outcome (DALS-15).
    Vogt S; Petri S; Dengler R; Heinze HJ; Vielhaber S
    J Pain Symptom Manage; 2018 Nov; 56(5):736-745.e2. PubMed ID: 30145215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea.
    Vogt S; Schreiber S; Heinze HJ; Dengler R; Petri S; Vielhaber S
    Health Qual Life Outcomes; 2019 Jun; 17(1):95. PubMed ID: 31159830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
    JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Turkish version of "the Dyspnea-ALS-Scale (DALS-15)".
    Kolbaşı EN; Açıkbaş E; Akşimşek GP; Aslan GK; Kıyan E
    Neurol Sci; 2022 Mar; 43(3):1823-1829. PubMed ID: 34387755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyspnea in amyotrophic lateral sclerosis: The Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment.
    Vogt S; Schreiber S; Kollewe K; Körner S; Heinze HJ; Dengler R; Petri S; Vielhaber S
    Respir Med; 2019; 154():116-121. PubMed ID: 31234039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
    Mehdipour A; Teshler L; Dal Bello-Haas V; Richardson J; Beauchamp M; Turnbull J; Chum M; Johnston W; O'Connell C; Luth W; Kuspinar A
    Phys Ther; 2023 Nov; 103(11):. PubMed ID: 37581600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
    Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Harrower T; Orrell RW; Annadale J; Hanemann CO; Scalfari A; Tennant A; Mills R;
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):475-485. PubMed ID: 38465877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of Spasticity Index-Amyotrophic Lateral Sclerosis.
    Milinis K; Tennant A; Mills RJ; Al-Chalabi A; Burke G; Dick DJ; Ealing J; Hanemann CO; Harrower T; McDermott CJ; Majeed T; Pinto A; Talbot K; Williams T; Young CA;
    Acta Neurol Scand; 2018 Jul; 138(1):47-54. PubMed ID: 29468643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-diagnostic validity of the SF-36 physical functioning scale in patients with stroke, multiple sclerosis and amyotrophic lateral sclerosis: a study using Rasch analysis.
    Dallmeijer AJ; de Groot V; Roorda LD; Schepers VP; Lindeman E; van den Berg LH; Beelen A; Dekker J;
    J Rehabil Med; 2007 Mar; 39(2):163-9. PubMed ID: 17351700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyspnea as a Fatigue-Promoting Factor in ALS and the Role of Objective Indicators of Respiratory Impairment.
    Vogt S; Schreiber S; Pfau G; Kollewe K; Heinze HJ; Dengler R; Petri S; Vielhaber S; Brinkers M
    J Pain Symptom Manage; 2020 Aug; 60(2):430-438.e1. PubMed ID: 32145336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale.
    Sun C; Fournier CN; Ye S; Zhang N; Ma Y; Fan D
    Eur J Neurol; 2021 Jun; 28(6):1876-1883. PubMed ID: 33686758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model.
    Kocher A; Ndosi M; Denhaerynck K; Simon M; Dwyer AA; Distler O; Hoeper K; Künzler-Heule P; Redmond AC; Villiger PM; Walker UA; Nicca D
    Orphanet J Rare Dis; 2021 Aug; 16(1):356. PubMed ID: 34372892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Internal Construct Validity and Unidimensionality of the Brachial Assessment Tool, A Patient-Reported Outcome Measure for Brachial Plexus Injury.
    Hill B; Pallant J; Williams G; Olver J; Ferris S; Bialocerkowski A
    Arch Phys Med Rehabil; 2016 Dec; 97(12):2146-2156. PubMed ID: 27478002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND).
    Gibbons CJ; Mills RJ; Thornton EW; Ealing J; Mitchell JD; Shaw PJ; Talbot K; Tennant A; Young CA
    Health Qual Life Outcomes; 2011 Nov; 9():101. PubMed ID: 22107756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis.
    Young C; Ealing J; McDermott C; Williams T; Al-Chalabi A; Majeed T; Roberts R; Mills R; Tennant A;
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):390-398. PubMed ID: 34709092
    [No Abstract]   [Full Text] [Related]  

  • 16. The amyotrophic lateral sclerosis supportive care needs assessment instrument: Development and psychometric evaluation.
    Oh J; Oh SI; Kim JA
    Palliat Support Care; 2018 Dec; 16(6):692-697. PubMed ID: 29375038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measures of dyspnea in patients with amyotrophic lateral sclerosis.
    Lechtzin N; Lange DJ; Davey C; Becker B; Mitsumoto H
    Muscle Nerve; 2007 Jan; 35(1):98-102. PubMed ID: 17029274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis.
    Franchignoni F; Mora G; Giordano A; Volanti P; Chiò A
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1340-5. PubMed ID: 23516308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Rasch-Built Amyotrophic Lateral Sclerosis Impairment Multidomain Scale to Measure Disease Progression in ALS.
    de Jongh AD; van Eijk RPA; Bakker LA; Bunte TM; Beelen A; van der Meijden C; van Es MA; Visser-Meily JMA; Kruitwagen ET; Veldink JH; van den Berg LH
    Neurology; 2023 Aug; 101(6):e602-e612. PubMed ID: 37311649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.